Total Payments
$11,776
2024 Payments
$329.86
Companies
29
Transactions
243
Medicare Patients
22,202
Medicare Billing
$1.1M
Payment Breakdown by Category
Food & Beverage$5,127 (43.5%)
Consulting$5,000 (42.5%)
Travel$1,392 (11.8%)
Education$142.41 (1.2%)
Other$115.00 (1.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,127 | 231 | 43.5% |
| Consulting Fee | $5,000 | 1 | 42.5% |
| Travel and Lodging | $1,392 | 6 | 11.8% |
| Education | $142.41 | 4 | 1.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $115.00 | 1 | 1.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Siemens Medical Solutions USA, Inc. | $5,419 | 7 | $0 (2022) |
| Corindus Inc. | $1,744 | 11 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $653.41 | 45 | $0 (2023) |
| ABIOMED | $489.18 | 4 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $437.47 | 17 | $0 (2020) |
| Amgen Inc. | $380.89 | 28 | $0 (2021) |
| SANOFI-AVENTIS U.S. LLC | $361.76 | 15 | $0 (2019) |
| Abbott Laboratories | $361.37 | 6 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $326.14 | 19 | $0 (2021) |
| Boston Scientific Corporation | $271.37 | 17 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $329.86 | 5 | Abbott Laboratories ($151.23) |
| 2023 | $229.74 | 4 | E.R. Squibb & Sons, L.L.C. ($124.74) |
| 2022 | $5,066 | 5 | Siemens Medical Solutions USA, Inc. ($5,028) |
| 2021 | $712.32 | 24 | Siemens Medical Solutions USA, Inc. ($292.32) |
| 2020 | $924.76 | 45 | AstraZeneca Pharmaceuticals LP ($186.76) |
| 2019 | $1,184 | 59 | ABIOMED ($294.64) |
| 2018 | $2,510 | 56 | Corindus Inc. ($1,543) |
| 2017 | $819.52 | 45 | Abbott Laboratories ($189.64) |
All Payment Transactions
243 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/02/2024 | Abbott Laboratories | THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) | Food and Beverage | In-kind items and services | $151.23 | General |
| Category: Heart Failure | ||||||
| 05/22/2024 | ABIOMED | Impella (Device) | Food and Beverage | In-kind items and services | $130.07 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 03/14/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $13.63 | General |
| Category: General - Therapies_CRM | ||||||
| 02/29/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $20.01 | General |
| Category: Cardiology | ||||||
| 02/26/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $14.92 | General |
| Category: General - Therapies_CRM | ||||||
| 11/17/2023 | Chiesi USA, Inc. | KENGREAL (Drug) | Food and Beverage | Cash or cash equivalent | $21.93 | General |
| Category: CARDIOVASCULAR | ||||||
| 04/07/2023 | ABIOMED | Impella (Device) | Food and Beverage | In-kind items and services | $64.47 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 03/20/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $18.60 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 02/06/2023 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $124.74 | General |
| Category: Cardiovascular | ||||||
| 10/07/2022 | Siemens Medical Solutions USA, Inc. | Artis icono floor (Device) | Food and Beverage | In-kind items and services | $17.05 | General |
| Category: AT - Fixed interventional x-ray/angiography fluoroscopy | ||||||
| 08/29/2022 | Regeneron Healthcare Solutions, Inc. | EVKEEZA (Biological) | Education | In-kind items and services | $21.73 | General |
| Category: CARDIOVASCULAR AND METABOLISM | ||||||
| 06/08/2022 | Siemens Medical Solutions USA, Inc. | CorPath Imaging System (Device) | Food and Beverage | In-kind items and services | $10.63 | General |
| Category: AT - Fixed interventional x-ray/angiography fluoroscopy | ||||||
| 04/22/2022 | Chiesi USA, Inc. | KENGREAL (Drug), CLEVIPREX | Food and Beverage | Cash or cash equivalent | $16.17 | General |
| Category: CARDIOVASCULAR | ||||||
| 03/01/2022 | Siemens Medical Solutions USA, Inc. | — | Consulting Fee | Cash or cash equivalent | $5,000.00 | General |
| 12/06/2021 | Siemens Medical Solutions USA, Inc. | CorPath Imaging System (Device) | Food and Beverage | In-kind items and services | $117.27 | General |
| Category: AT - Fixed interventional x-ray/angiography fluoroscopy | ||||||
| 11/18/2021 | Siemens Medical Solutions USA, Inc. | CorPath Imaging System (Device) | Food and Beverage | In-kind items and services | $144.93 | General |
| Category: AT - Fixed interventional x-ray/angiography fluoroscopy | ||||||
| 10/11/2021 | Siemens Medical Solutions USA, Inc. | CorPath Imaging System (Device) | Food and Beverage | In-kind items and services | $30.12 | General |
| Category: AT - Fixed interventional x-ray/angiography fluoroscopy | ||||||
| 06/23/2021 | Boston Scientific Corporation | GENERAL PAIN MANAGEMENT (Device) | Food and Beverage | In-kind items and services | $55.54 | General |
| Category: PAIN MANAGEMENT | ||||||
| 04/30/2021 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $20.08 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 04/27/2021 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $15.16 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 04/22/2021 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $16.34 | General |
| Category: Cardiovascular | ||||||
| 04/20/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.59 | General |
| Category: DIABETES | ||||||
| 04/19/2021 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $13.93 | General |
| Category: CARDIOVASCULAR | ||||||
| 04/15/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.83 | General |
| Category: DIABETES | ||||||
| 03/30/2021 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $22.81 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 21 | 4,629 | 6,467 | $983,077 | $232,533 |
| 2022 | 19 | 5,657 | 8,159 | $1.1M | $282,332 |
| 2021 | 21 | 6,779 | 9,676 | $1.4M | $345,594 |
| 2020 | 21 | 5,137 | 6,652 | $988,926 | $278,734 |
Total Patients
22,202
Total Services
30,954
Medicare Billing
$1.1M
Procedure Codes
95
All Medicare Procedures & Services
95 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 705 | 1,019 | $326,080 | $91,639 | 28.1% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 221 | 365 | $79,935 | $34,832 | 43.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 123 | 129 | $54,825 | $17,445 | 31.8% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 1,667 | 2,718 | $48,924 | $16,429 | 33.6% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 279 | 282 | $121,542 | $13,429 | 11.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 735 | 1,032 | $33,024 | $11,085 | 33.6% |
| 92928 | Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | Facility | 2023 | 14 | 19 | $25,536 | $8,711 | 34.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 57 | 57 | $25,080 | $6,577 | 26.2% |
| 93460 | Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 17 | 17 | $48,705 | $4,899 | 10.1% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 26 | 26 | $61,984 | $4,831 | 7.8% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 65 | 65 | $65,325 | $3,810 | 5.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 21 | 21 | $12,558 | $3,142 | 25.0% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Office | 2023 | 175 | 176 | $8,272 | $2,747 | 33.2% |
| 93350 | Ultrasound of heart during rest, exercise and/or drug-induced stress with report | Office | 2023 | 51 | 51 | $20,808 | $2,373 | 11.4% |
| 93312 | Ultrasound of heart with probe in esophagus, with report | Facility | 2023 | 28 | 28 | $14,672 | $2,273 | 15.5% |
| 92960 | External shock to heart to regulate heart beat | Facility | 2023 | 16 | 19 | $6,669 | $1,624 | 24.4% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Office | 2023 | 148 | 148 | $4,588 | $1,570 | 34.2% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 149 | 150 | $4,650 | $1,540 | 33.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 14 | 14 | $4,480 | $1,025 | 22.9% |
| 92978 | Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | Facility | 2023 | 11 | 12 | $8,568 | $950.88 | 11.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 12 | 12 | $2,604 | $737.16 | 28.3% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 57 | 69 | $2,829 | $702.56 | 24.8% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Office | 2023 | 17 | 17 | $306.00 | $111.18 | 36.3% |
| 93325 | Ultrasound of heart with color-depicted blood flow, rate and valve function | Facility | 2023 | 21 | 21 | $1,113 | $49.98 | 4.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 794 | 1,143 | $354,330 | $104,180 | 29.4% |
About Dr. William Devlin, MD
Dr. William Devlin, MD is a Interventional Cardiology healthcare provider based in Troy, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/16/2005. The National Provider Identifier (NPI) number assigned to this provider is 1871575860.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. William Devlin, MD has received a total of $11,776 in payments from pharmaceutical and medical device companies, with $329.86 received in 2024. These payments were reported across 243 transactions from 29 companies. The most common payment nature is "Food and Beverage" ($5,127).
As a Medicare-enrolled provider, Devlin has provided services to 22,202 Medicare beneficiaries, totaling 30,954 services with total Medicare billing of $1.1M. Data is available for 4 years (2020–2023), covering 95 distinct procedure/service records.
Ad
Practice Information
- Specialty Interventional Cardiology
- Other Specialties Cardiovascular Disease
- Location Troy, MI
- Active Since 11/16/2005
- Last Updated 09/30/2025
- Taxonomy Code 207RI0011X
- Entity Type Individual
- NPI Number 1871575860
Products in Payments
- ENTRESTO (Drug) $634.81
- Impella (Device) $489.18
- LifeVest (Device) $326.14
- Corlanor (Drug) $325.63
- CorPath Imaging System (Device) $302.95
- BRILINTA (Drug) $279.80
- XARELTO (Drug) $228.70
- CorPath GRX (Device) $217.96
- Vascepa (Drug) $187.29
- WATCHMAN (Device) $187.28
- PRALUENT (Drug) $184.86
- MULTAQ (Drug) $176.90
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) $151.23
- Absorb GT1 (Device) $144.57
- FARXIGA (Drug) $130.63
- CAMZYOS (Drug) $124.74
- Edwards SAPIEN 3 Transcatheter Heart Valve (Device) $98.77
- KENGREAL (Drug) $64.99
- JARDIANCE (Drug) $61.37
- GENERAL PAIN MANAGEMENT (Device) $55.54
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.